| Dr Stewart Raymond North, DO | |
|
1501 Hiland Ave, Burley, ID 83318-2688 | |
| (208) 678-4444 | |
| Not Available |
| Full Name | Dr Stewart Raymond North |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 1501 Hiland Ave, Burley, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225476450 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 033-T1 (Wyoming) | Secondary |
| 207Q00000X | Family Medicine | 060-T2 (Wyoming) | Secondary |
| 207Q00000X | Family Medicine | O-0952 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health Of Idaho | Nampa, ID | Home health agency |
| Intermountain Home Care Of Cassia | Burley, ID | Home health agency |
| Horizon Home Health East | Twin falls, ID | Home health agency |
| Harrison's Hope Twin Falls | Twin falls, ID | Hospice |
| Intermountain Homecare Hospice - Cassia | Burley, ID | Hospice |
| Cassia Regional Hospital | Burley, ID | Hospital |
| St Lukes Magic Valley Medical Center | Twin falls, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Appraisal Committee of the United Kingdom's National Institute for Health and Care Excellence has issued a positive Appraisal Consultation Document on ILUVIEN for the treatment of pseudophakic patients with chronic diabetic macular edema considered insufficiently responsive to available therapies.
Autonomic Technologies, Inc. (ATI), the developer of a novel miniaturized implantable stimulator for severe headaches, today announced initiation of a study in Europe to evaluate the safety and efficacy of the company's investigational neurostimulation system for the treatment of high frequency, high disability migraine.
A team led by Massachusetts General Hospital (MGH) scientists has developed a new microfluidic tool for quickly and accurately isolating neutrophils - the most abundant type of white blood cell - from small blood samples, an accomplishment that could provide information essential to better understanding the immune system's response to traumatic injury. The system, described in a Nature Medicine paper that received advance online release, also can be adapted to isolate almost any type of cell.
Emergent BioSolutions Inc. was pleased to sponsor the Security and Defence Agenda's (SDA) roundtable discussion, "Raising Biopreparedness Levels in Europe," which examined European efforts in preparing and reacting to various biological threats and the potential for European cooperation in these areas.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710156922 PECOS PAC ID: 1850209420 Enrollment ID: O20040325001015 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Appraisal Committee of the United Kingdom's National Institute for Health and Care Excellence has issued a positive Appraisal Consultation Document on ILUVIEN for the treatment of pseudophakic patients with chronic diabetic macular edema considered insufficiently responsive to available therapies.
Autonomic Technologies, Inc. (ATI), the developer of a novel miniaturized implantable stimulator for severe headaches, today announced initiation of a study in Europe to evaluate the safety and efficacy of the company's investigational neurostimulation system for the treatment of high frequency, high disability migraine.
A team led by Massachusetts General Hospital (MGH) scientists has developed a new microfluidic tool for quickly and accurately isolating neutrophils - the most abundant type of white blood cell - from small blood samples, an accomplishment that could provide information essential to better understanding the immune system's response to traumatic injury. The system, described in a Nature Medicine paper that received advance online release, also can be adapted to isolate almost any type of cell.
Emergent BioSolutions Inc. was pleased to sponsor the Security and Defence Agenda's (SDA) roundtable discussion, "Raising Biopreparedness Levels in Europe," which examined European efforts in preparing and reacting to various biological threats and the potential for European cooperation in these areas.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stewart Raymond North, DO 1501 Hiland Ave, Burley, ID 83318-2688 Ph: (208) 678-4444 | Dr Stewart Raymond North, DO 1501 Hiland Ave, Burley, ID 83318-2688 Ph: (208) 678-4444 |
News Archive
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Appraisal Committee of the United Kingdom's National Institute for Health and Care Excellence has issued a positive Appraisal Consultation Document on ILUVIEN for the treatment of pseudophakic patients with chronic diabetic macular edema considered insufficiently responsive to available therapies.
Autonomic Technologies, Inc. (ATI), the developer of a novel miniaturized implantable stimulator for severe headaches, today announced initiation of a study in Europe to evaluate the safety and efficacy of the company's investigational neurostimulation system for the treatment of high frequency, high disability migraine.
A team led by Massachusetts General Hospital (MGH) scientists has developed a new microfluidic tool for quickly and accurately isolating neutrophils - the most abundant type of white blood cell - from small blood samples, an accomplishment that could provide information essential to better understanding the immune system's response to traumatic injury. The system, described in a Nature Medicine paper that received advance online release, also can be adapted to isolate almost any type of cell.
Emergent BioSolutions Inc. was pleased to sponsor the Security and Defence Agenda's (SDA) roundtable discussion, "Raising Biopreparedness Levels in Europe," which examined European efforts in preparing and reacting to various biological threats and the potential for European cooperation in these areas.
› Verified 8 days ago
Mr. Ronald Bret Campbell, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 Hiland Ave, Suite A, Burley, ID 83318 Phone: 208-878-9432 Fax: 208-878-4576 | |
Mrs. Karrie Rae Kondel, ARNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1309 Bennett Ave, Burley, ID 83318 Phone: 208-678-7796 Fax: 360-838-2450 | |
David Miller, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1309 Bennett Ave, Burley, ID 83318 Phone: 208-678-7796 Fax: 208-678-7799 | |
Dr. Jeremy B Haymore, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 Hiland Ave, Burley, ID 83318 Phone: 208-677-6440 Fax: 208-677-6455 | |
Steven Boehmer, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1335 Albion Ave, Burley, ID 83318 Phone: 208-878-2271 | |
Matthew David Detemple, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1308 Bennett Ave, Burley, ID 83318 Phone: 208-678-7796 Fax: 208-678-7799 |